P. Wurmann

发表

Interstitial lung disease and microscopic polyangiitis in chilean patients

K. Vergara, M. Mac-Namara, M. L. Molina, 2020, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Cranial versus Extracranial Involvement in Giant Cell Arteritis: 15 Years Retrospective Cohort Analysis

M. Mac-Namara, P. Wurmann, F. Sabugo, 2022, Open access rheumatology : research and reviews.

Illness Experiences in Women with Oral Dryness as a Result of Sjögren's Syndrome: The Patient Point of View.

R. Geenen, G. Rojas-Alcayaga, P. Wurmann, 2016, Musculoskeletal care.

Diffuse Lymphadenopathy Syndrome as a Flare-Up Manifestation in Lupus and Mixed Connective Tissue Disease Following Mild COVID-19

L. Hojman, P. Wurmann, C. Karsulovic, 2021, The American journal of case reports.

Illness Experience and Quality of Life in Sjögren Syndrome Patients

R. Geenen, G. Rojas-Alcayaga, I. Espinoza, 2022, International journal of environmental research and public health.

[Variables associated with mortality in 103 patients with anti-neutrophil cytoplasmic antibodies associated vasculitis].

H. Gatica, A. Goecke, P. Wurmann, 2020, Revista medica de Chile.

Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets.

M. Molina, J. Aguillón, B. Pesce, 2011, Immunobiology.

Effect of interleukin‐6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients

M. Molina, J. Aguillón, B. Pesce, 2013, Clinical and experimental immunology.

[Retrospective review of 44 Chilean patients with Behçet disease].

J. Verdaguer, M. Cuchacovich, L. Soto, 2009, Revista medica de Chile.

B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcγRIIb, which are modulated by anti-tumor necrosis factor therapy

J. Aguillón, A. Kalergis, O. Aravena, 2010, Arthritis research & therapy.

Illness Experiences of Chilean Women With Sjögren’s Syndrome: The Patient Perspective

R. Geenen, G. Rojas-Alcayaga, P. Wurmann, 2020, Arthritis care & research.

The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism

J. Aguillón, L. Salazar, H. Gatica, 2011, Clinical Rheumatology.

Weak CD4+ T-cell responses to citrullinated vimentin in rheumatoid arthritis patients carrying HLA-DR9 alleles

A. Escobar, J. Aguillón, O. Aravena, 2012, Rheumatology International.